Про Hebecell corp

Про компанію

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases. The company's mission is to contribute to the fields of regenerative medicine and immuno-oncology by developing cell-based therapeutics. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a bioreactor, allowing them to reproduce indefinitely. HebeCell was established in 2016 and is headquartered in Natick, Massachusetts.